This week on The Midpoint, we’re joined by GP and media medic Dr Jack Mosley for a timely and much-needed conversation about GLP-1 medications — and what they really mean for our health in midlife.
Dr Mosley breaks down the science behind drugs like Ozempic and Wegovy, explaining how they work in the body, why they’ve become so popular, and what role they can (and should) play in weight management. With so much hype — and misinformation — surrounding these medications, he offers a clear, balanced view on who they’re for, the potential benefits, and the risks that are often overlooked.
We also explore the bigger picture: why midlife weight gain happens, how hormones, lifestyle and metabolism all intersect, and whether these medications are a long-term solution or simply part of a wider toolkit.
It’s an honest conversation about expectations, quick fixes, and the reality of sustainable health — without shame or judgment.
If you’ve been curious about GLP-1s, confused by the headlines, or wondering whether they might be right for you, this episode will help you make sense of it all.
Jack is working with The Fast 800 intermittent fasting plan. For a 7 day free trial of The Fast 800 online programme and for more info, please visit www.thefast800.com
Hosted on Acast. See acast.com/privacy for more information.